有害事象報告詳細
| VAERS ID | 1393351 |
|---|---|
| 性別 | 女性 |
| 年齢 | |
| 州コード | FR |
| 製薬会社 | ファイザー |
| ロット番号 | EW2445 |
| ワクチン接種回数 | 1 |
| 接種日 | 2021-05-20 |
| 発生日 | 2021-05-24 |
| 状態 |
症状
- SARS-CoV-2テスト(SARS-CoV-2 test)
- 妊娠検査(Pregnancy test)
- 月経が遅れる(Menstruation delayed)
罹患中の病気
持病
Medical History/Concurrent Conditions: Lactation decreased; UTI
その他医療
NITROFURANTOIN
以前のワクチン接種
アレルギー
臨床検査
Test Name: Pregnancy test; Test Result: Negative ; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative
症状詳細
Late period; This is a spontaneous report from a contactable Consumer.
This is a report received from the Medicines Healthcare products Regulatory Agency (MHRA).
Regulatory authority report number GB-MHRA-WEBCOVID-202105270826375990-WVWUJ, Safety Report Unique Identifier GB-MHRA-ADR 25369282.
A 23-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 20May2021 (Lot Number: EW2445) as 1ST DOSE, SINGLE DOSE for COVID-19 immunisation.
Medical history Lactation decreased, and UTI (urinary tract infection).
Patient has not had symptoms associated with COVID-19.
Patient is not enrolled in clinical trial.
Patient is not pregnant (at time of vaccination).
Patient is not currently breastfeeding.
Concomitant medication included Nitrofurantoin (Manufacturer unknown) taken for urinary tract infection from 13May2021 to 20May2021.
The patient experienced late period (medically significant) on 24May2021 with outcome of not recovered.
The patient underwent lab tests and procedures which included COVID-19 virus test: No - Negative, Pregnancy Test: Negative.
Patient has not tested positive for COVID-19 since having the vaccine.
No Follow-up attempts are possible.
No further information is expected.